Fariba Raygan

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 3

Top Topics

Early Breast Cancer

Placebo Controlled

Top Venues

International journal of clinical practice

This page only lists publications with an associated author ORCID identifier.

Publications

Zahra Vahedpour, Homa Boroumand, Shirin Tabatabaee Anaraki, Zohre Tabasi, Hossein Motedayyen, Hossein Akbari, Fariba Raygan, Vahidreza Ostadmohammadi
Effects of Isoflavone Supplementation on the Response to Medroxyprogesterone in Premenopausal Women with Nonatypical Endometrial Hyperplasia: A Randomized, Double-Blind, Placebo-Controlled Trial. International journal of clinical practice 2022 (2022)
Zahra Vahedpour, Homa Boroumand, Shirin Tabatabaee Anaraki, Zohre Tabasi, Hossein Motedayyen, Hossein Akbari, Fariba Raygan, Vahidreza Ostadmohammadi
Effects of Isoflavone Supplementation on the Response to Medroxyprogesterone in Premenopausal Women with Nonatypical Endometrial Hyperplasia: A Randomized, Double-Blind, Placebo-Controlled Trial. International journal of clinical practice 2022 (2022)
Zahra Vahedpour, Homa Boroumand, Shirin Tabatabaee Anaraki, Zohre Tabasi, Hossein Motedayyen, Hossein Akbari, Fariba Raygan, Vahidreza Ostadmohammadi
Effects of Isoflavone Supplementation on the Response to Medroxyprogesterone in Premenopausal Women with Nonatypical Endometrial Hyperplasia: A Randomized, Double-Blind, Placebo-Controlled Trial. International journal of clinical practice 2022 (2022)